XIENCE XPEDITION 1074300-18Recalls & reported problems
Abbott Vascular Inc. · XIENCE Xpedition Everolimus Eluting Coronary Stent System 3.00 mm x 18 mm / Rapid-Exchange · Class 3 · Implant
All models of XIENCE XPEDITION (41)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 08717648162343), received between Aug 27, 2018 and Jul 18, 2019 — classified as 1 injury, 1 malfunction.
The most frequently reported specific device problem is “Deflation Problem” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
- Deflation Problem1
- Difficult to Remove1
- Improper or Incorrect Procedure or Method1
Patient problems
- No Consequences Or Impact To Patient1
- Stenosis1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionJul 18, 2019Deflation Problem; Difficult to Remove; Improper or Incorrect Procedure or Method; Deflation Problem; Difficult to Remove; Improper or Incorrect Procedure or Method
IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT AN UNSPECIFIED LESION. AFTER STENT DEPLOYMENT OF A 3.0X18MM XIENCE XPEDITION, THE STENT-BALLOON FAILED TO DEFLATE. IT WAS DECIDED TO SIMPLY WITHDRAW THE STENT-BALLOON. NO HARM CAME TO THE PATIENT. REPORTEDLY, THE DEVICE WAS NOT PREPPED (AIR ASPIRATION) OUTSIDE THE ANATOMY PRIOR TO USE. THERE WERE NO ADVERSE PATIENT EFFECTS AND NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 8803242 ↗InjuryAug 27, 2018Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT IN (B)(6) 2018, THE PROCEDURE WAS PERFORMED USING TWO XIENCE XPEDITION STENTS TO TREAT A LESION IN THE MID RIGHT CORONARY ARTERY (RCA) WITH MILD CALCIFICATION. A 3.0 X 38 MM XIENCE XPEDITION STENT WAS IMPLANTED IN THE PROXIMAL RCA AND A 3.0 X 18 MM XIENCE XPEDITION STENT WAS IMPLANTED IN THE MID RCA. ON (B)(6) 2018, THE PATIENT PRESENTED WITH ACUTE CORONARY SYNDROME FROM A DE NOVO BLOCKAGE. ANGIOGRAPHY REVEALED THE STENTS HAD 70-80% RESTENOSIS IN THE RCA IN BOTH XIENCE XPEDITION STENTS. BALLOON ANGIOPLASTY WAS PERFORMED TO TREAT THE RESTENOSIS. PER THE PHYSICIAN, THE CAUSE OF THE RESTENOSIS WAS UNDER EXPANSION OF THE STENT. THE LEFT ANTERIOR ARTERY WAS ALSO TREATED. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: Stenosis
MAUDE report 7820023 ↗
Other Coronary drug-eluting stent devices
- SYNERGY™ H7493926038300Boston Scientific Corporation · Coronary drug-eluting stent8 deaths124 reports
- SYNERGY™ H7493926016300Boston Scientific Corporation · Coronary drug-eluting stent7 deaths106 reports
- SYNERGY™ H7493926020300Boston Scientific Corporation · Coronary drug-eluting stent9 deaths90 reports
- SYNERGY™ H7493926016250Boston Scientific Corporation · Coronary drug-eluting stent6 deaths82 reports
- XIENCE Sierra™ 1550350-33Abbott Vascular Inc. · Coronary drug-eluting stent1 recall32 reports
- Resolute Onyx™ RONYX30022UXMedtronic, Inc. · Coronary drug-eluting stent6 deaths76 reports
- SYNERGY™ H7493926024300Boston Scientific Corporation · Coronary drug-eluting stent3 deaths75 reports
- Resolute Onyx™ RONYX30015UXMedtronic, Inc. · Coronary drug-eluting stent3 deaths73 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page